Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Prevention: What's New at HFA 2025?
Author(s): Harriette Van Spall , Maja Cikes Added: 1 year ago
ESC HF 25 - Join experts, Dr Harriette Van Spall (McMaster University, CA) and Dr Maja Cikes (University Hospital Centre Zagreb, HR) for an insightful wrap up of the novel data concerning preventive cardiology that was presented at 2025's Heart Failure Congress.Trials discussed include:REDICAE (00:42)FINEARTS HF (02:27)CRISPR Gene Editing with Nexiguran Ziclumeran (05:53)HELIOS B (07:12)RESHAPE… View more

Heart Failure
Complication Prevention in Complex AF and VT Procedures
Author(s): Pasquale Santangeli , Dhanunjaya Lakkireddy Added: 4 months ago
Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, Kansas City, US) and Dr Pasquale Santangeli (Cleveland Clinic, Cleveland, OH, US) discuss evidence-based strategies for preventing complications during complex atrial fibrillation and ventricular tachycardia ablation procedures.This expert discussion focuses on safety considerations in high-risk electrophysiology procedures, comparing… View more

Electrophysiology & Arrhythmia
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC
Author(s): Josep Rodés-Cabau Added: 7 months ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device… View more

Anticoagulation

Imaging & Diagnostics
30th Annual Meeting of the ISCP
Author(s): Jessica Ares-Blanco , Miguel García-Villarino , Carmen Lambert , et al Added: 2 months ago

Prevention & Chronic Conditions

Demographic
30th Annual Meeting of the ISCP
Author(s): María Iglesias Alonso , Jose Manuel Iglesias Sanmartin Added: 2 months ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
30th Annual Meeting of the ISCP
Author(s): Raúl Ptaszynski Lanza , Fernando López Iglesias , Raúl Ludeña , et al Added: 2 months ago

Prevention & Chronic Conditions

Guidelines & Statements
30th Annual Meeting of the ISCP
Author(s): Jordi Cahís , Pablo Carrión-Montaner , Jordi Sans , et al Added: 2 months ago

Prevention & Chronic Conditions
30th Annual Meeting of the ISCP
Author(s): Miguel García-Villarino , Elias Delgado , Carmen Lambert , et al Added: 2 months ago

Prevention & Chronic Conditions

Demographic
hsCRP Improves CV Risk Prediction in Primary Prevention
Added: 2 months ago Source:  Radcliffe CVRM
High-sensitivity C-reactive protein (hsCRP), a marker of inflammation, has a debated role in primary cardiovascular (CV) prevention. A large, population-based study using UK Biobank data has provided further insight into its utility as a clinical biomarker for identifying individuals at residual risk who do not have known atherosclerotic cardiovascular disease (ASCVD).¹MethodologyThis population… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
The Future of Heart Failure With Dr Yancy
Author(s): Clyde W Yancy Added: 6 months ago
AHA Scientific Sessions 2025 - Dr Clyde Yancy (Northwestern University, US) joins us to explore the future trajectory of heart failure management, examining how prevention strategies, precision medicine approaches, and the evolving responsibilities of cardiologists are reshaping patient outcomes.Interview Questions:Looking at the current state of heart failure management, what do you see as the… View more

Guidelines & Statements

Heart Failure